chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400066, PJP200400067, PJP200400068, PJP200400069, PJP200400070, PJP200400071, PJP200400072, PJP200400073, PJP200400074, PJP200400075, PJP200400076, PJP200400077, PJP200400078, PJP200400079.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400067, PJP200400068, PJP200400069, PJP200400070, PJP200400071, PJP200400072, PJP200400073, PJP200400074, PJP200400075, PJP200400076, PJP200400077, PJP200400078, PJP200400079.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400068, PJP200400069, PJP200400070, PJP200400071, PJP200400072, PJP200400073, PJP200400074, PJP200400075, PJP200400076, PJP200400077, PJP200400078, PJP200400079.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400069, PJP200400070, PJP200400071, PJP200400072, PJP200400073, PJP200400074, PJP200400075, PJP200400076, PJP200400077, PJP200400078, PJP200400079.
Age: 0.74
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200400070, PJP200400071, PJP200400072, PJP200400073, PJP200400074, PJP200400075, PJP200400076, PJP200400077, PJP200400078, PJP200400079.
Age: 0.82
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200400069, PJP200400071, PJP200400072, PJP200400073, PJP200400074, PJP200400075, PJP200400076, PJP200400077, PJP200400078, PJP200400079.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200400069, PJP200400070, PJP200400072, PJP200400073, PJP200400074, PJP200400075, PJP200400076, PJP200400077, PJP200400078, PJP200400079.
Age: 1.09
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200400069, PJP200400070, PJP200400071, PJP200400073, PJP200400074, PJP200400075, PJP200400076, PJP200400077, PJP200400078, PJP200400079.
Age: 1.47
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200400069, PJP200400070, PJP200400071, PJP200400072, PJP200400074, PJP200400075, PJP200400076, PJP200400077, PJP200400078, PJP200400079.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200400069, PJP200400070, PJP200400071, PJP200400072, PJP200400073, PJP200400075, PJP200400076, PJP200400077, PJP200400078, PJP200400079.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200400069, PJP200400070, PJP200400071, PJP200400072, PJP200400073, PJP200400075, PJP200400076, PJP200400077, PJP200400078, PJP200400079.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200400069, PJP200400070, PJP200400071, PJP200400072, PJP200400073, PJP200400074, PJP200400075, PJP200400077, PJP200400078, PJP200400079.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200400069, PJP200400070, PJP200400071, PJP200400072, PJP200400073, PJP200400074, PJP200400075, PJP200400076, PJP200400078, PJP200400079.
Age: 1.39
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200400069, PJP200400070, PJP200400071, PJP200400072, PJP200400073, PJP200400074, PJP200400075, PJP200400076, PJP200400077, PJP200400079.
Age: 1.35
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400063, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200400069, PJP200400070, PJP200400071, PJP200400072, PJP200400073, PJP200400074, PJP200400075, PJP200400076, PJP200400077, PJP200400078.
Age: 2.5
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 13Jan04 concerning a 2.5 year old female vaccinee who received Fluvirin on 12Jan04. On 12Jan04 the vaccinee received Fluvirin. The vaccinee did not have any complaint as a result. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Fatigue, Myalgia
Clinical narrative: A report was received from a health care professional on 13Jan04, concerning a 48 year old female who developed generalized myalgia and fatigue 5 days after she received Fluvirin on 20Nov03. On 20Nov03 the vaccinee received Fluvirin. On 25Nov03 the vaccinee began experiencing generalized myalgia. The fatigue and myalgia have persisted and were still present at the time of reporting. The vaccinee is being followed by her general practitioner who is in the process of determining the cause of her fatigue. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.8
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 13Jan04, concerning a 21 month old male vaccinee who inadvertently received Fluvirin on 13Jan04. On 13Jan04, the vaccinee inadvertently received Fluvirin. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 01Mar04, follow up information received from a health care professional indicated that the vaccinee did not experience any adverse events following inadvertent Fluvirin vaccination. No follow up pending, all information received.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health professional on 05Dec03, concerning a 2 year old female vaccinee who inadvertently received Fluvirin on 26Nov03. On 26Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Cross reference with: PJP200301247, PJP200400085, PJP200400086.
Age: 0.54
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health professional on 05Dec03, concerning a 6 month old male vaccinee who inadvertently received Fluvirin on 28Nov03. On 28Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Cross reference with: PJP200301247, PJP200400084, PJP200400086.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health professional on 05Dec03, concerning a 2 year old female vaccinee who inadvertently received Fluvirin on 01Dec03. On 01Dec03 the vaccinee inadvertently received Fluvirin. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Cross reference with: PJP200301247, PJP200400084, PJP200400085.
Sex: U
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 15Dec03 concerning approximately 10 children of unk sex and less than 4 years of age who inadvertently received Fluvirin between the 22Oct03 and 10Dec03. Between 22Oct03 and 10Dec03 approx 10 children inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Cross reference with PJP200301313.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health professional on 16Jan04  concerning a 3 year old male vaccinee who inadvertently received Fluvirin on an unspecified date. On an unspecified date the vaccinee inadvertently received 0.25ml.  It was reported that the administration did not cause the vaccinee harm. There was insufficient information to determine the reporter's causality assessment. Follow up pending.  See reference: PJP200400102.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning an unspecified number (approximately 5 to 6) vaccinees under 4 years of age who inadvertently received Fluvirin on unspecified dates. On unspecified dates, the vaccinee inadvertently received Fluvirin 0.5ml IM. The vaccinees did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1/20/04: A follow up report was received from a health care professional concerning a 3 year old male vaccinee who inadvertently received Fluvirin on 11/5/03. On 11/5/03 the vaccinee inadvertently received Fluvirin. No adverse effects were reported at the time of reporting. No follow up pending. All information received.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning an unspecified number (approximately 5 to 6) vaccinees under 4 years of age who inadvertently received Fluvirin on unspecified dates. On unspecified dates, the vaccinees inadvertently received Fluvirin 0.5ml IM. The vaccinees did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1/20/04: A follow up report was received from a health care professional concerning a 3 year old male vaccine who inadvertently received Fluvirin on 11/5/03. On 11/5/03 the vaccinee inadvertently received Fluvirin. No adverse effects were reported at the time of reporting. No follow up pending. All information received.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning an unspecified number (approximately 5 to 6) vaccinees under 4 years of age who inadvertently received Fluvirin on unspecified dates. On unspecified dates, the vaccinees inadvertently received Fluvirin 0.5ml IM> The vaccinees did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1/20/04: A follow up report was received from a health care professional concerning a 3 year old female vaccinee who inadvertently received Fluvirin on 11/17/03. On 11/17/03 the vaccinee inadvertently received Fluvirin. No adverse effects were reported at the time of reporting. No follow up pending. All information received.
Age: 0.67
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning an unspecified number (approximately 5 to 6) vaccinees under 4 years of age who inadvertently received Fluvirin on unspecified dates. On unspecified dates, the vaccinees inadvertently received Fluvirin 0.5ml IM. The vaccinees did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1/20/04: A follow up report was received from a health care professional concerning an 8 month old male vaccinee who inadvertently received Fluvirin on 11/20/03. On 11/20/03 the vaccinee inadvertently received Fluvirin. No adverse effects were reported at the time of reporting. No follow up pending. All information received.
Age: 0.59
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/2/03 concerning an unspecified number (approximately 5 to 6) vaccinees under 4 years of age who inadvertently received Fluvirin on unspecified dates. On unspecified dates, the vaccinees inadvertently received Fluvirin 0.5ml IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1/20/04: A follow up report was received from a health care professional concerning a 7 month old female vaccinee who inadvertently received Fluvirin on 11/25/03. On 11/25/03 the vaccinee inadvertently received Fluvirin. No adverse effects were reported at the time of reporting. No follow up pending. All information received.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a consumer on 1/20/04 concerning a 2.5 year old female vaccinee who inadvertently received 0.25ml Fluvirin on an unspecified date in December 2003 and on 1/9/04 inadvertently received a booster vaccine of 0.25ml Fluvirin. On an unspecified date in December 2003, the vaccinee inadvertently received 0.25ml Fluvirin and on 1/9/04 inadvertently received a booster vaccine of 0.25ml Fluvirin. At the time of the report no adverse events had been reported. Update 2/23/04: Follow up information received received from a health care professional indicated that the vaccinee received Fluzone on 12/5/03 instead of Fluvirin as previously recorded. The vaccinee did not have experience any adverse reactions. No follow up pending.
Age: 45.0
Sex: M
Vaccine: FLU3
Symptoms: Tinnitus
Clinical narrative: A report was received from a health care professional on 1/21/04 concerning a 45 year old male vaccinee who developed low frequency tinnitus lasting several months, 2 weeks after he received Fluvirin on 10/14/02. On 10/14/02 the vaccinee received Fluvirin. About 2 weeks later in November 2002 he developed a low frequency tinnitus that lasted several months and resolved by late summer 2003. In fall 2003, the vaccinee received Fluzone and the tinnitus returned. According to the vaccinee at the time of reporting the symptoms had mostly resolved, but are not 100% resolved. There was insufficient information to determine the reporter's causality assessment. Follow up pending
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/8/03 concerning an unknown number of children of unspecified sex and less than 4 years of age who inadvertently received Fluvirin on an unknown date. On an unknown date, an unspecified number of children less than 4 years of age inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.36
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/3/03 concerning eight vaccinees of unspecified sex and under 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date, eight vaccinees under 4 years of age inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality. Update 1/20/04: Follow up information received from a health care professional indicated that a 16 month old male vaccinee inadvertently received Fluvirin on 11/21/03. No follow up pending.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/3/03 concerning eight vaccinees of unspecified sex and under 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date, eight vaccinees under 4 years of age inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality. Update 1/20/04: Follow up information received from a health care professional indicated that a 2 year old female vaccinee inadvertently received Fluvirin on 11/18/03. No follow up pending.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/3/03 concerning eight vaccinees of unspecified sex and under 4 years of age who inadvertently received Fluvirin on an unspecified date. On an  unspecified date, eight vaccinees under 4 years of age inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality. Update 1/20/04: Follow up information received from a health care professional indicated that a 2 year old male vaccinee inadvertently received Fluvirin on 11/26/03. No follow up pending.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/03/03 concerning eight vaccinees of unspecified sex and under 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date, eight vaccinees under 4 years of age inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality. Update 1/20/04: Follow up information received from a health care professional indicated that a 3.5 year old female vaccinee inadvertently received Fluvirin on 11/18/03. No follow up pending.
Age: 30.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error, Pain, Pharyngitis, Rhinitis
Clinical narrative: A report was received from a health care professional on 1/27/04 concerning a 30 year old female vaccinee who developed soreness in her arm after she received Fluvirin on 12/10/03, while she was 15 weeks pregnant. On 12/10/03, the vaccinee received Fluvirin into her right deltoid. The vaccinee reported that her arm was sore for a week afterwards and then resolved completely. After Christmas holidays the vaccinee developed a minor cold and reported that her arm began to feel sore again. The vaccinee experienced 2 additional episodes of minor cold/illness during which the soreness in her arm returned. This was the vaccinee's first experience to the influenza vaccine. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Medication error
Clinical narrative: A report was received from a health care professional on 1/28/04 concerning a female vaccinee of unspecified age who developed redness and soreness at the injection site after inadvertently receiving a sub-optimal dose (0.1ml) of Fluvirin ID on 1/26/04, instead of Tuberculin skin test. On 1/26/04 the vaccinee received 0.1ml Fluvirin ID instead of Tuberculin skin test. The vaccinee has complained of redness and soreness at the injection site. There was insufficient information to determine the reporter's causality assessment. Update 3/12/04: Further information was received from a health care professional indicating that the vaccinee experienced redness and soreness at the injection site on 1/28/04 which lasted for 2 days. The vaccinee did not experience any further effects. Follow up pending.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 1/30/04 concerning approximately 40 vaccinees under 4 years of age and of unknown gender, who inadvertently received Fluvirin on unspecified dates in December 2003 and January 2004. On unspecified dates in December 2003 and January 2004 the vaccinee inadvertently received Fluvirin. No adverse effects were reported at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.37
Sex: F
Vaccine: FLU3
Symptoms: Medication error, Pain
Clinical narrative: A report was received from a health care professional on 2/3/04 concerning a 15 month old female vaccinee who inadvertently received Fluvirin on 2/3/04. On 2/3/04 the vaccinee inadvertently received Fluvirin. No adverse effects were reported at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 5/4/04: A follow up report received from a health care professional indicated that the vaccinee was 16 months old and experienced a slightly sore leg but no fever on the same day as receiving Fluvirin on 2/3/04. The vaccinee had also received Fluzone on a different side on 1/2/04. The vaccinee recovered on an unspecified date. No follow up pending. All information received.
Sex: F
Vaccine: FLU3
Symptoms: Influenza like illness, Muscular weakness, Pharyngolaryngeal pain
Clinical narrative: A report was received from a health care professional on 2/4/04 concerning a female vaccinee of approximately 72 years of age who experienced a sore throat, flu-like symptoms and bilateral lower extremity weakness after receiving Fluvirin on an unspecified date in October 2003. The vaccinee had a previous history of neuropathy in her feet. On an unspecified date in October 2003, the vaccinee experienced a sore throat in the evening after receiving Fluvirin. A few days later, the vaccinee developed mild flu-like symptoms. At the time of the report, the vaccinee was experiencing bilateral lower extremity weakness which was greater in the right than in the left. The outcome of the events was not reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 5.0
Sex: M
Vaccine: FLU3
Symptoms: Accidental overdose, Medication error
Clinical narrative: A report was received from a health care professional on 2/4/04 concerning a 5 year old male vaccinee who inadvertently received half of the correct dose of Fluvirin on an unspecified date. On an unreported date, the vaccinee received 0.25ml Fluvirin. The vaccinee did not experience any adverse events at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 3/15/04: Further information was received from a health care professional indicated that the vaccinee received half of the correct dose of Fluvirin on 12/3/03. The outcome was unknown at the time of the report. The vaccinee received a second dose of Fluvirin at the correct dose on 1/8/04. Follow up pending.
Age: 8.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 2/4/04 concerning an 8 year old female vaccinee who inadvertently received half of the correct dose of Fluvirin on an unspecified date. On an unspecified date, the vaccinee received 0.25ml Fluvirin. The vaccinee did not experience any adverse events at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 3/15/04: Further information received from a health care professional indicated that the vaccinee received half of the correct dose of Fluvirin on 12/3/03. The outcome was unknown at the time of the report. The vaccinee received a second dose of Fluvirin at the correct dose on 1/8/04. Follow up pending.
Age: 3.0
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 2/5/04 concerning a 3 and a half year old vaccinee of unspecified gender who inadvertently received Fluvirin on 1/29/04. On 1/29/04 the vaccinee inadvertently received Fluvirin. No adverse effects were reported at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 2/16/04 concerning a 3 year old female vaccinee who inadvertently received Fluvirin on 12/5/03. On 12/5/03, the vaccinee inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. No follow up pending.
Age: 1.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 2/16/04 concerning a 1 year old female vaccinee who inadvertently received Fluvirin on 12/5/03. On 12/5/03, the vaccinee inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. No follow up pending.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 2/16/04 concerning a 2 year old female vaccinee who inadvertently received Fluvirin on 10/31/03 and 12/3/03. On 10/31/03 and 12/3/03, the vaccinee inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. No follow up pending.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 2/16/04 concerning a 3.5 year old male vaccinee who inadvertently received Fluvirin on 10/10/03 and 11/10/03. On 10/10/03 and 11/10/03, the vaccinee inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. No follow up pending.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 2/16/04 concerning a 2 year old male vaccinee who inadvertently received Fluvirin on 11/13/03. On 11/13/03, the vaccinee inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. No follow up pending.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site swelling, Pruritus, Urticaria
Clinical narrative: A report was received from a health care professional on 10/29/03 concerning an unspecified number of vaccinees of unspecified demography who experienced localized hives, swelling, redness and itching and unspecified length of time after receiving Fluvirin on an unknown date. On an unknown date an unspecified number of vaccinees experienced localized hives, swelling, redness and itching on an unspecified length of time after receiving Fluvirin. The reporter noted many more local adverse effects than usual with the 2003-2004 Fluvirin. It was not reported if the vaccinee's had recovered at the time of the report. There was insufficient information to determine the reporter's causality. Update 2/16/04: A follow up report was received from a health care professional indicating that a 44 year old female vaccinee developed redness and swelling at the injection site, which was also itchy after receiving Fluvirin on 10/14/03. The outcome of the adverse events was not reported at the time of reporting. Update 4/16/04: Further follow up information received from a health care professional indicated that the vaccinee's symptoms resolved and no further symptoms were reported as of April 2004. No follow up pending. All information received.
Age: 11.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site swelling, Pruritus, Urticaria
Clinical narrative: A report was received from a health care professional on 10/29/03 concerning an unspecified number of vaccinees of unspecified demography who experienced localized hives, swelling, redness and itching an unspecified length of time after receiving Fluvirin on an unknown date. On an unknown date an unspecified number of vaccinees experienced localized hives, swelling, redness and itching on an unspecified length of time after receiving Fluvirin. The reporter noted many more local adverse effects than usual with the 2003-2004 Fluvirin. It was not reported if the vaccinee's had recovered at the time of the report. There was insufficient information to determine the reporter's causality. Update 2/16/04: A follow up report was received from a health care professional indicating that an 11 year old female vaccinee developed an event described as red, swelling and itchy on 10/14/03, 1 day after receiving Fluvirin on 10/13/03. The outcome of the adverse event was not reported at the time of reporting. Update 4/16/04: Further follow up information received from a health care professional indicated that the vaccinee's symptoms resolved and no further symptoms were reported as of 4/04. No follow up pending. All information received.
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site swelling, Injection site warmth, Pruritus
Clinical narrative: A report was received from a health care professional on 10/29/03 concerning an unspecified number of vaccinees of unspecified demography who experienced localized hives, swelling, redness and itching an unspecified length of time after receiving Fluvirin on an unknown date. On an unknown date an unspecified number of vaccinees experienced localized hives, swelling, redness and itching of an unspecified length of time after receiving Fluvirin. The reporter noted many more local adverse effects than usual with the 2003-2004 Fluvirin. It was not reported if the vaccinee's had recovered at the time of the report. There was insufficient information to determine the reporter's causality. Update 2/16/04: A follow up report was received from a health care professional indicating that a female vaccinee of unspecified age developed redness and swelling at the injection site which was warm to touch after receiving Fluvirin on 10/16/03. The vaccinee also developed a fever. The outcome of the adverse events was not reported at the time of reporting. Update 4/16/04: Further follow up information received from a health care professional indicated that the vaccinee's symptoms resolved and no further symptoms were reported as of 4/04. No follow up pending.
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia, Urticaria
Clinical narrative: A report was received from a health care professional on 10/29/03 concerning an unspecified number of vaccinees of unspecified demography who experienced localized hives, swelling, redness and itching an unspecified length of time after receiving Fluvirin on an unknown date. On an unknown date an unspecified number of vaccinees experienced localized hives, swelling, redness and itching of an unspecified length of time after receiving Fluvirin. The reporter noted many more local adverse effects than usual with the 2003-2004 Fluvirin. It was not reported if the vaccinee's had recovered at the time of the report. There was insufficient information to determine the reporter's causality. Update 2/16/04: A follow up report was received from a health care professional indicating that a female vaccinee of unspecified age developed redness and swelling at the injection site which was warm to touch after receiving Fluvirin on 10/16/03. The vaccinee also developed a fever. The outcome of the adverse events was not reported at the time of reporting. Update 4/16/04: Further follow up information received from a health care professional indicated that the vaccinee's symptoms resolved and no further symptoms were reported as of 4/04. No follow up pending.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site swelling, Injection site warmth, Pruritus
Clinical narrative: A report was received from a health care professional on 10/29/03 concerning an unspecified number of vaccinees of unspecified demography who experienced localized hives, swelling, redness and itching an unspecified length of time after receiving Fluvirin on an unknown date. On an unknown date an unspecified number of vaccinees experienced localized hives, swelling, redness and itching on an unspecified length of time after receiving Fluvirin. The reporter noted many more local adverse effects than usual with the 2003-2004 Fluvirin. It was not reported if the vaccinee's had recovered at the time of the report. There was insufficient information to determine the reporter's causality. Update 2/16/04: A follow up report was received from a health care professional indicating that a 44 year old female vaccinee developed redness and swelling at the injection site which was warm to touch after receiving Fluvirin on 10/27/03. The outcome of the adverse events was not reported at the time of reporting. Update 4/16/04: Further follow up information received from a health care professional indicated that the vaccinee's symptoms resolved and no further symptoms were reported as of 4/04. No follow up pending. All information received.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: A report was received from a health care professional on 10/29/03 concerning an unspecified number of vaccinees of unspecified demography who experienced localized hives, swelling, redness and itching an unspecified length of time after receiving Fluvirin on an unknown date. On an unknown date an unspecified number of vaccinees experienced localized hives, swelling, redness and itching on an unspecified length of time after receiving Fluvirin. The reporter noted many more local adverse effects than usual with the 2003-2004 Fluvirin. It was not reported if the vaccinee's had recovered at the time of the report. There was insufficient information to determine the reporter's causality. Update 2/16/04: A follow up report was received from a health care professional indicating that a 44 year old female vaccinee developed redness and swelling at the injection site which was warm to touch after receiving Fluvirin on 10/27/03. The outcome of the adverse events was not reported at the time of reporting. Update 4/16/04: Further follow up information received from a health care professional indicated that the vaccinee's symptoms resolved and no further symptoms were reported as of 4/04. No follow up pending. All information received.